Bio Essence Corp financial data

Symbol
BIOE on OTC
Industry
Pharmaceutical Preparations
Location
12 Chrysler Unit B, Irvine, CA
State of incorporation
California
Fiscal year end
December 31
Latest financial report
10-Q/A - Q2 2024 - Aug 21, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21.3 % +183%
Quick Ratio 6.07 % -5.3%
Debt-to-equity -218 % -38.1%
Return On Equity 36.9 % +14.2%
Return On Assets -31 % +44.8%
Operating Margin -143 % -74%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38M shares 0%
Common Stock, Shares, Outstanding 38M shares 0%
Entity Public Float 1.27M USD 0%
Common Stock, Value, Issued 3.8K USD 0%
Weighted Average Number of Shares Outstanding, Basic 38M shares +9.5%
Weighted Average Number of Shares Outstanding, Diluted 38M shares +9.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 41.7K USD -83.9%
Cost of Revenue 12.5K USD -91.7%
General and Administrative Expense 1.16M USD +332%
Operating Income (Loss) -949K USD -383%
Nonoperating Income (Expense) -4.38K USD +37%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -933K USD -279%
Income Tax Expense (Benefit) 800 USD -50%
Net Income (Loss) Attributable to Parent -590K USD +32.6%
Earnings Per Share, Basic 0 USD/shares 0%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.49K USD +1654%
Accounts Receivable, after Allowance for Credit Loss, Current 7.89K USD -26.5%
Inventory, Net 143K USD -20.9%
Assets, Current 917K USD +332%
Property, Plant and Equipment, Net 3.69K USD -98.5%
Operating Lease, Right-of-Use Asset 1.18M USD +20.8%
Intangible Assets, Net (Excluding Goodwill) 450 USD -34.3%
Other Assets, Noncurrent 53.3K USD
Assets 2.1M USD +40.3%
Accounts Payable, Current 59.6K USD +47.8%
Accrued Liabilities, Current 3.3K USD -51.1%
Liabilities, Current 3.11M USD +104%
Operating Lease, Liability, Noncurrent 673K USD -22%
Other Liabilities, Noncurrent 56.1K USD
Liabilities 3.84M USD +45.1%
Retained Earnings (Accumulated Deficit) -9.22M USD -6.84%
Stockholders' Equity Attributable to Parent -1.74M USD -51.2%
Liabilities and Equity 2.1M USD +40.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -172K USD +25.9%
Net Cash Provided by (Used in) Financing Activities 172K USD -23.9%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -6.14K USD -7765%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.49K USD +1654%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.7K USD -20.2%
Deferred Tax Assets, Valuation Allowance 624K USD -61%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 623K USD
Operating Lease, Liability 1.39M USD
Depreciation 16.3K USD +6.94%
Lessee, Operating Lease, Liability, to be Paid 1.56M USD
Property, Plant and Equipment, Gross 56.5K USD -87.8%
Operating Lease, Liability, Current 721K USD +306%
Lessee, Operating Lease, Liability, to be Paid, Year Two 588K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 571K USD
Deferred Income Tax Expense (Benefit) 3.2K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 125K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 400K USD
Current Income Tax Expense (Benefit) 3.2K USD 0%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 7.48M USD 0%
Amortization of Intangible Assets 235 USD 0%
Interest Expense 542 USD -2.17%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%